Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to

Suman Gangopadhyay1, Farid Jalali, Danny Reda

  • 1Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada.

Insights

p53

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The role of p53 in determining chemosensitivity and radiosensitivity is complex and debated.
  • Previous studies on p53's impact on treatment response have yielded conflicting results.

Purpose of the Study:

  • To investigate the role of wild-type and mutant p53 in neuroblastoma cell sensitivity to genotoxic agents.
  • To clarify the relationship between p53 status, apoptosis, cell cycle arrest, and DNA repair in response to irradiation.

Main Methods:

  • Utilized isogenic clones derived from neuroblastoma cell lines (Nub7 and IMR32) expressing wild-type p53.
  • Introduced two distinct mutant p53 transgenes to disrupt p53 function.
  • Assessed cellular sensitivity to gamma radiation and evaluated apoptosis, G1 cell cycle arrest, and DNA double-strand break rejoining.

Main Results:

  • Cellular response to genotoxic agents varied based on the specific agent and the introduced p53 transgene.
  • No correlation was found between cellular radiosensitivity, apoptosis, or G1 arrest.
  • A significant association was observed between gamma-radiation sensitivity and DNA double-strand break rejoining activity.

Conclusions:

  • The impact of p53 on radiosensitivity is not solely dependent on apoptosis or G1 arrest.
  • DNA double-strand break repair efficiency is a key factor influencing radiosensitivity in the context of p53 function.
  • Understanding p53's complex role is crucial for predicting and improving cancer therapy outcomes.